Verastem | VSTM - Ingresos Por Ventas





Ventas Cambio Fecha
AbbVie USD 15B 1.62B 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
AstraZeneca USD 15.29B 213M 2026-03
Curis USD 1.14M 1.41M 2025-12
Cytokinetics USD 19.35M 1.59M 2026-03
Gilead Sciences USD 7B 930M 2026-03
Incyte USD 1.27B 240M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Novartis USD 13.11B 226M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
TG Therapeutics USD 194.8M 2.23M 2026-03
Verastem USD 17.54M 7.53M 2025-12